[Form 4] Amrize Ltd Insider Trading Activity

Rhea-AI Filing Summary

Amrize Ltd (AMRZ) disclosed that director Holli C. Ladhani received a restricted stock unit award for 2,958 ordinary shares under the Amrize Ltd 2025 Omnibus Incentive Plan. The award was reported as an acquisition on 08/11/2025 at a reported price of $0 and is shown as direct beneficial ownership of 2,958 shares following the transaction. The restricted stock units vest on the earlier of the one-year anniversary of the grant date or the issuer’s next regular annual meeting of shareholders, meaning the shares may convert to ownership within that timeframe if vesting conditions are met.

Positive

• Director Holli C. Ladhani was granted 2,958 restricted stock units under the Amrize Ltd 2025 Omnibus Incentive Plan, increasing direct beneficial ownership to 2,958 shares.
• Vesting terms are explicit: the award vests on the earlier of the one-year anniversary of the grant date or the issuer's next regular annual meeting of shareholders.

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine director RSU grant of 2,958 shares; disclosure appears to be standard compensation with limited immediate market impact.

The Form 4 reports a non-derivative award: 2,958 restricted stock units granted to director Holli C. Ladhani under the 2025 Omnibus Incentive Plan. The transaction is recorded as an acquisition on 08/11/2025 at a price of $0, and the award vests on the earlier of one year or the next regular annual meeting of shareholders. This filing documents the resulting direct beneficial ownership of 2,958 shares. As reported, the disclosure is a routine insider compensation event rather than a sale or market-moving change in ownership.

Corporate Governance Expert

TL;DR: Standard governance disclosure of a director RSU grant with near-term vesting; reflects compensation under the company’s 2025 plan.

The report specifies the award was made pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan and includes explicit vesting conditions: vesting occurs on the earlier of the one-year anniversary of grant or the issuer’s next regular annual meeting of shareholders. The filing lists the resulting direct beneficial ownership of 2,958 ordinary shares. This is a routine insider award disclosure used to inform shareholders of changes in insider holdings and the terms under which shares may become fully owned.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ladhani Holli C.

(Last) (First) (Middle)

GRAFENAUWEG 8

(Street)

ZUG V8 6300

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Amrize Ltd [ AMRZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/11/2025		A		2,958(1)	A	$0	2,958	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on the earlier of the one-year anniversary of the grant date and the date of the issuer's next regular annual meeting of shareholders.

	Hans Weinburger, Attorney-in-Fact	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Amrize (AMRZ) Form 4 report?

The Form 4 reports that director Holli C. Ladhani was granted 2,958 restricted stock units, resulting in direct beneficial ownership of 2,958 ordinary shares.

When was the transaction for the AMRZ insider grant?

The transaction date shown on the Form 4 is 08/11/2025.

Under what plan were the AMRZ RSUs awarded?

The restricted stock unit award was granted pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan.

What are the vesting conditions for the awarded RSUs in AMRZ?

The award vests on the earlier of the one-year anniversary of the grant date or the date of the issuer's next regular annual meeting of shareholders.

What price was reported for the AMRZ award?

The transaction is reported at a price of $0 on the Form 4.